Exact Mass: 639.332168

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins

34a-Deoxyrifamycin W

34a-Deoxy-rifamycin W

Moxidectin

21,24-dihydroxy-4-(methoxyimino)-5,11,13,22-tetramethyl-6-(4-methylpent-2-en-2-yl)-3,7,19-trioxaspiro[oxane-2,6-tetracyclo[15.6.1.1^{4,8}.0^{20,24}]pentacosane]-10,14,16,22-tetraen-2-one

DG(8:0/LTE4/0:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-{[(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl]oxy}-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

DG(8:0/LTE4/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/LTE4/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(LTE4/8:0/0:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2S)-3-hydroxy-2-(octanoyloxy)propoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

DG(LTE4/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(LTE4/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(8:0/0:0/LTE4)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2R)-2-hydroxy-3-(octanoyloxy)propoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

DG(8:0/0:0/LTE4) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(LTE4/0:0/8:0)

(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-3-[(2S)-2-hydroxy-3-(octanoyloxy)propoxy]-3-oxopropyl]sulphanyl}-5-hydroxyicosa-7,9,11,14-tetraenoic acid

DG(LTE4/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Leueantine A

C36H49NO9 (639.3407144)

Phoslactomycin E

Moxidectin

Pesticide4_Moxidectin_C37H53NO8_(1R,2R,4Z,4S,5S,6S,8R,10E,13R,14E,16E,20R,21R,24S)-21,24-Dihydroxy-4-(methoxyimino)-5,11,13,22-tetramethyl-6-[(2E)-4-methyl-2-penten-2-yl]-3,4,5,6-tetrahydro-2H-spiro[pyran-2,6-[3,7,19]trioxatetracyclo[15.6.1.1~4,8~.0~20,24~]pentacosa[10,14,16,22]tetraen]-2-one

P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics C254 - Anti-Infective Agent > C276 - Antiparasitic Agent D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals CONFIDENCE standard compound; INTERNAL_ID 1144

Hexosyl LPE 18:2

C31H49N3O9S (639.3189344000001)

Annotation level-3

Me ester-Leukotriene C4

petrosifungin B

C33H45N5O8 (639.326797)

(32S,52S)-31-[N-(N-acetyl-N-methyl-L-isoleucyl)-L-isoleucyl]-14-methoxy-(32rH,33tH)-2-oxa-7-aza-1(1,4)-benzena-3(3,2),5(1,2)-dipyrrolidina-cyclononaphan-8c-ene-4,6-dione|N-Acetyl-ziziphin-B|N-acetyl-zizyphine-B|N-acetyl-zizyphinine

(32S,52S)-31-[N-(N-acetyl-N-methyl-L-isoleucyl)-L-isoleucyl]-14-methoxy-(32rH,33tH)-2-oxa-7-aza-1(1,4)-benzena-3(3,2),5(1,2)-dipyrrolidina-cyclononaphan-8c-ene-4,6-dione|N-Acetyl-ziziphin-B|N-acetyl-zizyphine-B|N-acetyl-zizyphinine

C34H49N5O7 (639.3631803999999)

EKYSN

Glu Lys Tyr Ser Asn

C27H41N7O11 (639.2863916)

FLVMM

Phe-Leu-Val-Met-Met

C30H49N5O6S2 (639.3124094000001)

HLDQQ

His Leu Asp Gln Gln

C26H41N9O10 (639.2976246000001)

Leukotriene C4 methyl ester

5S-hydroxy-6R-(S-glutathionyl)-7E,9E,11Z,14Z-eicosatetraenoic acid, methyl ester

C31H49N3O9S (639.3189344000001)

N-methyl Leukotriene C4

N-methyl-5S-hydroxy-6R-(S-glutathionyl)-7E,9E,11Z,14Z-eicosatetraenoic acid

C31H49N3O9S (639.3189344000001)

Am-Hex-LPE 18:2

N-(1-deoxyfructosyl)-1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine

Cyclooctaselenium

Se8 (639.332168)

Cydectin

Moxidectin

P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

Chaxamycin A

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins

34a-Deoxy-rifamycin W

(2E,4E,11R)-12-[(4S,4aR,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-11-hydroxydodeca-2,4-dienoic acid

(2E,4E,11R)-12-[(4S,4aR,6R,8S,8aR)-4-[[(2S)-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetyl]amino]-8-methoxy-7,7-dimethyl-4a,6,8,8a-tetrahydro-4H-pyrano[3,2-d][1,3]dioxin-6-yl]-11-hydroxydodeca-2,4-dienoic acid

C33H53NO11 (639.3618428)

(4Z,10E,14E,16E)-21,24-dihydroxy-4-methoxyimino-5,11,13,22-tetramethyl-6-[(E)-4-methylpent-2-en-2-yl]spiro[3,7,19-trioxatetracyclo[15.6.1.14,8.020,24]pentacosa-10,14,16,22-tetraene-6,2-oxane]-2-one

P - Antiparasitic products, insecticides and repellents > P02 - Anthelmintics > P02C - Antinematodal agents D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000871 - Anthelmintics D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals

DG(8:0/LTE4/0:0)

DG(LTE4/8:0/0:0)

DG(8:0/0:0/LTE4)

DG(LTE4/0:0/8:0)

(5Z,9alpha,13E,15S)-9-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-11-oxoprosta-5,13-dien-1-oate

(5Z,11alpha,13E,15S)-11-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-9-oxoprosta-5,13-dien-1-oate

(5Z,11beta,13E,15S)-11-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-9-oxoprosta-5,13-dien-1-oate

(5Z,9beta,13E,15S)-9-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-15-hydroxy-11-oxoprosta-5,13-dien-1-oate

(5S,6R,7E,9E,14Z)-6-({(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-3-[(carboxylatomethyl)amino]-3-oxopropyl}sulfanyl)-5-hydroxy-12-oxoicosa-7,9,14-trienoate

(6Z,8Z,10S,11S,12R,13R,14S,15R,16S,17S,19Z)-11,13,15,17,22-pentahydroxy-18-(hydroxymethyl)-6,10,12,14,16,20,23-heptamethyl-11,12,13,14,15,16,17,18-octahydro-1H-3,25-methano-4-benzazacyclotricosine-1,5,21,26(4H,10H)-tetrone

(6Z,8Z,10S,11S,12R,13R,14S,15R,16S,17S,19Z)-11,13,15,17,22-pentahydroxy-18-(hydroxymethyl)-6,10,12,14,16,20,23-heptamethyl-11,12,13,14,15,16,17,18-octahydro-1H-3,25-methano-4-benzazacyclotricosine-1,5,21,26(4H,10H)-tetrone

2-amino-3-[[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

[1-hydroxy-3-[hydroxy-[2-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]ethoxy]phosphoryl]oxypropan-2-yl] (9E,12E)-octadeca-9,12-dienoate

[2-hydroxy-3-[hydroxy-[2-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]amino]ethoxy]phosphoryl]oxypropyl] (2E,4E)-octadeca-2,4-dienoate

(2S)-2-amino-3-[[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid

(2S)-2-amino-3-[[3-[(E)-dec-4-enoyl]oxy-2-[(5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid